TRIM33 and cancer: Interestingly, plasma VEGF-A, TNF-α, CCL2, IL-6, and IFN-γ cytokines levels were significantly enhanced in the Untreated Cancer TIF1-γ-DM group than in the Non-cancer TIF1-γ-DM group.